UBS Group AG - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 35 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2019$14,000
-84.9%
67,318
-66.3%
0.00%
Q2 2019$93,000
+34.8%
199,735
+26.9%
0.00%
Q1 2019$69,000
+40.8%
157,454
-0.7%
0.00%
Q4 2018$49,000
+96.0%
158,577
+361.1%
0.00%
Q3 2018$25,000
+525.0%
34,390
+224.5%
0.00%
Q2 2018$4,000
-93.3%
10,599
-90.5%
0.00%
Q1 2018$60,000
+30.4%
111,579
+61.1%
0.00%
Q4 2017$46,000
+12.2%
69,265
-2.3%
0.00%
Q3 2017$41,000
-86.7%
70,907
-80.8%
0.00%
Q2 2017$309,000
+30800.0%
369,685
+73837.0%
0.00%
Q1 2017$1,0005000.0%0.00%
Q4 2016$0
-100.0%
500
-94.6%
0.00%
Q3 2016$5,000
+66.7%
9,180
+65.9%
0.00%
Q2 2016$3,0005,533
+1006.6%
0.00%
Q1 2016$0
-100.0%
500
-37.5%
0.00%
Q4 2015$1,000
-75.0%
800
-78.3%
0.00%
Q3 2015$4,000
+100.0%
3,685
+360.6%
0.00%
Q2 2015$2,000
-77.8%
800
-84.5%
0.00%
Q1 2015$9,000
+200.0%
5,163
+212.5%
0.00%
Q4 2014$3,0001,6520.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Camber Capital Management LP 13,275,000$8,496,0000.41%
Broadfin Capital, LLC 2,025,268$1,296,0000.13%
Baillie Gifford 6,361,364$4,071,0000.01%
Spark Investment Management LLC 73,200$46,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 302,588$194,0000.00%
WEDBUSH SECURITIES INC 18,000$12,0000.00%
Financial Architects, Inc 10,000$6,0000.00%
Psagot Value Holdings Ltd. 22,050$14,0000.00%
BARCLAYS PLC 629,591$403,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 800,900$513,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders